Alembic Pharmaceuticals Ltd today said its consolidated net profit rose by 11.69% to Rs 42.49 crore for the second quarter ended September 30, over the same period of previous fiscal.
The company had posted a net profit of Rs 38.04 crore during the same period of previous financial year, Alembic Pharmaceuticals said in a filing to the BSE.
Total income of the company for the second quarter stood at Rs 406.85 crore, compared to Rs 397.99 crore during the same period of 2011-12 fiscal.
For the six months ended September 30, 2012, the company posted a net profit of Rs 73.33 crore, as against Rs 65.60 crore in the corresponding period of previous fiscal.
Shares of Alembic Pharmaceuticals today closed at Rs 69.70 on the BSE, down 1.27% from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app